31 Questions
What is the primary method of administering blood products during a blood transfusion?
Intravenous administration
Which of the following blood products is not typically used in modern transfusions?
Whole blood
What is the primary indication for transfusing Packed Red Blood Cells (PRBCs)?
To treat low hemoglobin levels
What is the name of the process of transferring blood products to a person?
Blood transfusion
What is the learning objective related to blood transfusions?
Inventory the indications for and the considerations regarding blood transfusion and reactions
What is the primary reason for using blood components instead of whole blood in transfusions?
To provide more specific therapy for patients with specific blood disorders
Which of the following blood products is used to help manage bleeding disorders?
Clotting Factor Concentrates
What is the primary indication for transfusing Packed Red Blood Cells (PRBCs) other than anemia?
Acute blood loss
What is the primary consideration regarding blood transfusions?
The risk of transfusion reactions
What is the role of Granulocyte in blood transfusions?
To increase white blood cell count
What is the primary purpose of transfusing Packed Red Blood Cells (PRBCs)?
To increase oxygen delivery to tissues
What is the most common indication for transfusing blood products?
Anemia
Which of the following blood products is not typically transfused?
Whole blood
What is the primary goal of transfusion medicine?
To improve patient outcomes
What is the primary benefit of using blood components instead of whole blood?
Improving the effectiveness of transfusions
What is the primary cause of chronic myeloid leukemia (CML)?
A genetic mutation in hematopoietic stem cells
What is the characteristic of the elevated white blood cells in CML patients?
They are mature cells, such as neutrophils and monocytes
What was the primary goal of initial treatments for CML?
To slow the proliferation of blood cells
What is the outcome of CML patients who develop acute leukemia?
They are often incurable with conventional chemotherapy
What is the significance of understanding the cause of CML?
It enables the development of intelligent and targeted treatments
What is the challenge of using bone marrow transplantation to treat CML?
Finding a bone marrow match for patients is not always possible
What is a characteristic of CML patients' bone marrow?
A marked increase in the production and maturation of blood cells
What is the outcome of CML patients who do not receive treatment?
They will eventually develop acute leukemia
What is the result of the reciprocal translocation between the 9th and 22nd chromosome?
Fusion of the breakpoint cluster region gene and the Abelson gene
What is the effect of the tyrosine kinase generated by the BCR-ABL fusion gene?
Increased cell division rates and decreased apoptosis
What is the primary advantage of using targeted therapies like STI-571 in the treatment of CML?
They are more targeted to the specific genetic mutation causing the disease
What is the result of the mutated stem cells having increased cell division rates?
They are more likely to acquire new genetic mutations
What is the significance of STI-571 in the treatment of cancer?
It is the first targeted therapy to be used in treating CML
What is the outcome of the initial clinical trial using STI-571 in patients with CML?
Dramatic responses were seen in patients, including those who had previously failed conventional therapies
What is the outcome of the continued development of targeted therapies for CML?
Multiple analogs of STI-571 have been developed, with different side effects and efficacy
What is the result of the BCR-ABL fusion gene in patients with CML?
Increased production of abnormal stem cells
Study Notes
Blood Transfusions
- Blood transfusion is the transfer of blood products to a person via intravenous administration.
- Whole blood transfusions were used in the past, but now only blood components are used.
- The components of blood transfusions include:
- Packed Red Blood Cells (PRBCs)
- Fresh Frozen Plasma
- Clotting Factor Concentrates
- Cryoprecipitate
- Platelets
- Granulocyte
- PRBCs are used when:
- Hemoglobin (Hg) levels are low
Blood Transfusions
- Blood transfusion is the transfer of blood products to a person via intravenous administration.
- Whole blood transfusions were used in the past, but now only blood components are used.
- The components of blood transfusions include:
- Packed Red Blood Cells (PRBCs)
- Fresh Frozen Plasma
- Clotting Factor Concentrates
- Cryoprecipitate
- Platelets
- Granulocyte
- PRBCs are used when:
- Hemoglobin (Hg) levels are low
Blood Transfusions
- Blood transfusion is the transfer of blood products to a person via intravenous administration.
- Whole blood transfusions were used in the past, but now only blood components are used.
- The components of blood transfusions include:
- Packed Red Blood Cells (PRBCs)
- Fresh Frozen Plasma
- Clotting Factor Concentrates
- Cryoprecipitate
- Platelets
- Granulocyte
- PRBCs are used when:
- Hemoglobin (Hg) levels are low
Regulation of Blood Cell Production
- The production of new blood cells is tightly controlled, and a single genetic mutation can lead to overproduction.
- Chronic myeloid leukemia (CML) is an example of what happens when hematopoietic stem cells acquire mutations.
Characteristics of CML
- CML was first described in the 1800s, characterized by elevated levels of blood cells, particularly white blood cells, and enlarged spleens.
- Patients with CML have elevated levels of mature blood cells, including neutrophils, monocytes, eosinophils, and basophils.
- Platelet count is often elevated, and high levels of blood cells can cause symptoms.
Early Treatment of CML
- Initial treatments aimed to slow blood cell proliferation to keep blood counts normal.
- Chemotherapy agents were used to try to control the disease, but patients eventually developed acute leukemia, which was often incurable with conventional chemotherapy.
Breakthroughs in Understanding CML
- The Philadelphia chromosome was identified as a result of a reciprocal translocation between the 9th and 22nd chromosomes.
- The fusion gene generated by this translocation, BCR-ABL, produces a tyrosine kinase that activates multiple signaling pathways, increasing cell division rates and decreasing apoptosis.
Development of Targeted Therapy
- Researchers hypothesized that a drug inhibiting the tyrosine kinase could treat CML.
- STI-571 (imatinib) was identified as an effective inhibitor of growth in laboratory tests and was selected for clinical trials.
- The initial trial showed dramatic responses with oral medication, even in patients who had failed conventional therapies.
Impact of Targeted Therapy
- STI-571 was approved by the FDA in 2001 and can effectively put patients into complete remission.
- The success of imatinib led to the development of multiple other targeted therapies for cancer.
- Researchers continue to work on improving responses for CML patients, with several analogs of imatinib now approved.
Learn about blood transfusions, including indications, considerations, and reactions. Understand the aspects of transfusion medicine.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
